# Probiotics and Microbiota in Bariatric Surgery

> **NCT01922830** · NA · UNKNOWN · sponsor: **Tel-Aviv Sourasky Medical Center** · enrollment: 100 (estimated)

## Conditions studied

- NAFLD

## Interventions

- **DIETARY_SUPPLEMENT:** Bio-25 (Supherb)
- **DIETARY_SUPPLEMENT:** Placebo (for Bio-25, Supherb)

## Key facts

- **NCT ID:** NCT01922830
- **Lead sponsor:** Tel-Aviv Sourasky Medical Center
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-10
- **Primary completion:** 2019-01
- **Final completion:** 2019-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2018-07-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01922830

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01922830, "Probiotics and Microbiota in Bariatric Surgery". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01922830. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*